Aprepitant has long been proven to inhibit the two the acute and delayed emesis induced by cytotoxic chemotherapeutic medication by blocking compound P landing on receptors from the brain's neurons. Positron emission tomography (PET) experiments, have demonstrated that aprepitant can cross the blood brain barrier and bind to NK1 receptors https://znl02-09614678.prublogger.com/26646619/new-step-by-step-map-for-ecomustine